Rx Medicare

Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational product candidate, Acetavance(TM) (intravenous acetaminophen), for the treatment of acute pain and fever in adults and children.

Read More…

Related Posts

• Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review For Intravenous Acetaminophen By Three Months
• New Drug Application Submitted To FDA For Tapentadol Extended Release Tablets For Management Of Chronic Pain
• FDA Approves New Drug Treatment For Long-Term Pain Relief After Shingles Attacks
• Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)
• Combined Drug Treatment More Effective Than Either Alone At Reducing Neuropathic Pain
• Promising Results In Reducing Neuropathic Pain With Combined Drug Treatment, Than With Either Drug Alone
• China Aoxing Pharmaceutical Company Announces Submission Of NDA Of Its Leading Narcotic Drug For The Treatment Of Acute Moderate To Severe Cough
• Lilly Resubmits Cymbalta(R) Supplemental New Drug Application For Chronic Pain To U.S. Food And Drug Administration
• KAI Pharmaceuticals Initiates Third Phase 2a Study In Program To Develop KAI-1678 For The Treatment Of Neuropathic Pain
• Non-drug techniques reduce pain in hospitalized patients
• Migraine With Aura: Magnetic Stimulation Is A Promising Non-Drug Treatment Option
• Cognitive Behavioral Therapy: Beneficial And Low Cost Treatment For Back Pain
• Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal
• Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation
• Study examines course and treatment of unexplained chest pain

Tags: acetavance, acute, application, cadence, drug, fever, pain, pharmaceuticals, submits, treatment

This entry was posted on Sunday, May 17th, 2009 at 9:05 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.